DS-01® Daily Synbiotic

DS-01® Daily Synbiotic

Name: DS-01® Daily Synbiotic
Brand: Seed Health
SKU: seed-ds01
Price: 60.0 USD
Availability: InStock

Microbiome · Capsule · 30 portioner#1 / 1 in Microbiome

6.4

Overall score · out of 10

6.4

Overall score · out of 10

Dose vs. studies5.6

Transparency8.5

Value6.5

Community7.5

Formulation5.0

Tier 1

Product RCT (peer-reviewed)

Strongest evidence: a peer-reviewed RCT tested this exact product.

Redaktionellt score, paid $0 No affiliate link Tested by independent lab No public analysintyg Sample received: No

How we scored this product Show the full breakdown

Dose vs. studies (55%) 5.6

Transparency (20%) 8.5

Value (10%) 6.5

Community sentiment (10%) 7.5

Formulation (5%) 5.0

Composite 6.4

6.4 composite

Dose vs. studies55%5.6

Transparency20%8.5

Value10%6.5

Community10%7.5

Formulation5%5.0

Bevisning gates dose: the evidence grade sets the ceiling, and the dose decides how much of that ceiling the product reaches. Value = inverse of price-per-trial-dose-day. Community = mean sentiment of external reviews. Säkerhet caps applied after weighting.

This score is our editorial judgment, not a scientific standard. We combine published evidence, dose, price, transparency, and consumer signals into one composite: this is our method, not a peer-reviewed clinical rating. A higher score means a product does better on the factors we weight, not that it is medically proven to work.

Read the full method →

Question 1

Does the molecule work?

The science behind each active ingredient, independent of which brand sells it.

Probiotics Grade B

Strain-specific benefits; forget 'total CFU' marketing.

No landmark RCTs listed · US: Dietary supplement · EU: Food supplement (some strains Novel Food)

Question 2

Is this bottle good?

The specific product: dose, price, transparency, and what buyers report.

Dose vs research

Not measurable

Trial dose not established for this ingredient

Cost at trial dose

Not calculable

What one effective daily dose actually costs

Transparency

8.5/10 · No public analysintyg

Independent batch testing confirmed

Consumer signals

No consumer signals collected yet

Operational signal only, never used as clinical evidence

Question 3

What's the catch?

Säkerhet flags, transparency gaps, dosing concerns, and recurring buyer complaints.

No public analysintyg

Certificate of Analysis not published

Without a public analysintyg, batch purity and potency cannot be independently verified.

Best for

Basic coverage

Avoid if

No public analysintyg

Full-dose status

Not measurable

Pris/month

$60

COA status

Not public

Biggest caveat

No public Certificate of Analysis.

Nearest alternatives

AG1 Foundational Nutrition AG1 (Athletic Greens) · Poäng 5.9
Seed AM-02 Energy + Focus Seed Health · Poäng 5.4
Seed PM-02 Sleep + Restore Seed Health · Poäng 5.4

The numbers

Pris

$60

per bottle · 30 portioner

Dose vs. research

n/a

of published effective dose

$ / day at studied dose

n/a

what one effective daily dose costs

$ / g active

$2.22

per gram of active substance

Independently checked

Data verification

Pris

$60

Verified n/a

Dose

Not measurable

Verified n/a

COA status

Not public

Verified n/a

Bevisning grade

Per-ingredient breakdown

BProbiotics

Verified n/a

All product data is checked against original sources. Prices, doses, and testing status are updated when product pages change. Bevisning grades are reviewed when new human RCTs are published. Read how we verify.

What's inside

Ingredient

Dose in this product

Trial dose

Bevisning

Probiotics

Strain-specific benefits; forget 'total CFU' marketing.

900 mg

n/a mg

3.6 /5

Medium confidence

Rated on 2 platforms (2 sources, no structured review counts)

Source diversity: 46%

RedditTrustpilot

PraiseCommunity highlights scientific advisory quality.

Last checked: 2026-08-07

Consumer signals

Consumer signals gathered from 2 platforms.

Medium confidence

Consumer sentiment compiled from 2 public sources (Reddit, Trustpilot).

Trustpilot

3.8/5 · mixed sentiment

Themes3.8/5. Positive for formulation; users cite price and subscription-cancel friction.

Compiled from a Trustpilot listing located during manual research; not independently re-verified against the live page at build time.

1 threads discussed · positive sentiment

PraiseCommunity highlights scientific advisory quality.

Compiled from a Reddit r/microbiome listing located during manual research; not independently re-verified against the live page at build time.

These are consumer sentiment signals. They do not measure whether the product actually works. See our evidence section for that.

Independent external anchors

Public sources on this same product, unrelated to NO1GEVITY. NIH DSLD is the US government's registered label database (shown verbatim). SuppCo.com is a separate, unaffiliated commercial site with no partnership or data-sharing arrangement with us. NO1GEVITY scores are computed independently of both.

Unaffiliated third-party site

SuppCo.com

SuppCo is a separate, unaffiliated supplement-tracking site with no partnership, data-sharing agreement, or business relationship with NO1GEVITY. We are not endorsed by them and they do not endorse us. The two facts below are individually verified against the manufacturer or NSF; the outbound link is provided only so readers can independently cross-check on a third-party site if they want to.

Tested by independent lab, Yes

What others say, with a source hierarchy

We treat external opinion very differently depending on where it comes from. Tier A is our strongest signal. Tier C is background sentiment only. Tier Rejected is what we excluded, listed openly so you can see what we discarded.

These reviews are aggregated from third-party sources, not written by NO1GEVITY. Each entry shows its source, retrieval date, and whether the source has an affiliate or paid relationship. We do not edit reviews to change their meaning. Disclosure policy.

Tier A

Independent deep reviews, lab tests, certificates of analysis

Our strongest external evidence. Long-form independent reviews, physical-product lab work, and third-party certifications.

Innerbody Research

Has affiliate relationship Not a paid placement

Innerbody's teardown concludes DS-01 contains clinically relevant strain counts and doses, with strong independent literature support for some strains (e.g., B. longum BB536, B. breve BR3) but weaker support for others; it flags the subscription cost as high relative to comparable produkter and notes real-world tester experience of reduced bloating.

Finding: Editor's efficacy rating of 7.0/10; notes DS-01 at $49.99/30-day supply ($1.67/day)

How we use it: Used as a Tier A source; Innerbody discloses its affiliate model but tests/evaluates the actual product and label claims directly rather than repackaging marketing, meeting our two-question test.

Healthline Nutrition (medically reviewed by Imashi Fernando, MS, RDN, CDCES; written by Ellen Landes, MS, RDN, CPT)

Has affiliate relationship Not a paid placement

A dietitian-reviewed comparison piece that treats DS-01 as a credible, well-formulated synbiotic among several reviewed produkter, without uncritical marketing repetition.

Finding: Confirms $49.99/30-day price and AFU count (reported as 56.3 billion AFU in Healthline's table vs. Seed's own 53.6 billion figure, a discrepancy worth noting for buyers)

How we use it: Used as Tier A; Healthline's nutrition team discloses methodology and uses named, credentialed reviewers (RDN/CDCES), consistent with the brief's acceptance criteria for outlets with disclosed methodology.

Good Housekeeping (Good Housekeeping Institute)

Has affiliate relationship Not a paid placement

First-person, three-month use trial by a GH Institute staffer alongside standard product-testing disclosure practices; describes a genuinely tested experience rather than a repackaged press release.

Finding: Confirms $49.99/30-day subscription price, ~10-15% refill-program discount, and $59.99 non-subscription retail (Target) pricing

How we use it: Used as Tier A for pricing/logistics corroboration; GHI is an established consumer-testing institution with disclosed affiliate relationships.

Better Business Bureau (BBB), Seed Health, Inc.

No affiliate relationship Not a paid placement

Complaint themes mirror Trustpilot: absence of live customer-service contact, subscription billing frustration, and some product-experience complaints (e.g., a Gastroparesis patient's account). No indication of regulatory action or fraud findings, this reflects service-quality friction, not a safety or efficacy verdict.

Finding: BBB business rating: B; customer review average 1.22/5 (32 reviews)

How we use it: Used as a consumer-protection-agency-adjacent Tier A source per the brief's hierarchy; corroborates the Trustpilot pattern independently rather than duplicating it.

Tier B

Registered dietitians and physicians, without affiliate ties

Credentialed commentary from clinicians who disclose no paid relationship. Useful as supporting critique but not a substitute for a clinical outcome trial.

Trustpilot (seed.com)

No affiliate relationship Not a paid placement

The large majority of negative reviews center on unauthorized recurring charges, difficulty cancelling subscriptions, absence of a direct customer-service phone line, and delivery/damaged-product issues, not on whether the probiotic itself works. A minority of reviews question product effectiveness.

Finding: 1.6/5 overall (116 reviews total, ~108 rated), markedly poor rating dominated by subscription/billing and customer-service complaints rather than product-efficacy complaints

How we use it: Used with disclosure per Tier B rules: N=116 is below the N>500 threshold the brief prefers, so we weight this cautiously. The rating is far more a signal about Seed's subscription/customer-service operations than about DS-01's biological efficacy, and we present it as such rather than folding it into an efficacy verdict. Contrasts sharply with the 4.6/10,000+ rating Seed publishes on its own product page (https://seed.com/reviews), which is not independently verified and is excluded as a self-reported vendor metric.

r/Microbiome (Reddit), 'What's your review of SEED DS-01 Daily Synbiotic'

No affiliate relationship Not a paid placement

Thread shows a split: several users call Seed 'one of the most reputable brands' and 'the most complete and researched pre/probiotic blend,' while at least one self-identified Seed employee states 'I work there. I don't take it,' and one long-term user reports feeling better after stopping.

Finding: No quantitative rating; mixed qualitative thread with several affiliate-link promotional comments flagged by other users

How we use it: Used per brief guidance for subreddit meta-threads with disclosed context; treated as anecdotal sentiment rather than evidence, and we flag the mixed/self-contradictory nature of the thread (including undisclosed affiliate promotion within it) rather than citing it as a clean endorsement.

r/Microbiome (Reddit), 'Did anyone else get wrecked by Seed probiotics?'

No affiliate relationship Not a paid placement

A user reports severe GI distress (burping, bloating, GERD, nausea, 20 lb weight loss) that resolved after stopping DS-01 ahead of a GI diagnostic workup; commenters note the strain diversity makes it hard to pinpoint a causal mechanism and caution that 'more strains' is not inherently better for every gut.

Finding: 145 upvotes on the original post; multiple corroborating comments

How we use it: Used as a Tier B anecdotal signal consistent with Seed's own labeled 'acclimation period' warning (mild GI discomfort expected in the first weeks) but illustrating that for a minority of users this can be severe and persistent rather than transient. We do not treat a single Reddit anecdote as establishing an adverse-event rate, but it is a legitimate data point on tolerability variance that the vendor's own materials also acknowledge in milder form.

Community threads and aggregate ratings

Additional public mentions we located, kept separate from the deep independent reviews above.

Trustpilot · 3.8

mixed

3.8/5. Positive for formulation; users cite price and subscription-cancel friction.

Read source → Unverified · we received no payment for this listing

Reddit r/microbiome

positive

Community highlights scientific advisory quality.

Read source → Unverified · we received no payment for this listing

Vår sammanfattning

Seed DS-01 Daily Synbiotic stands out in a category where the overwhelming majority of finished produkter carry no clinical evidence at all: it has at least two peer-reviewed, placebokontrollerad RCTs run on the exact 53.6-billion-AFU, 24-strain, 400 mg-pomegranate-prebiotic formula sold today, including a 350-person, 6-week trial published in Nutrients (2026) showing significant reductions in bloating and improvements in bowel regularity versus placebo. That places its strongest claims at Tier 1-2, well above the Tier 3-5 ceiling most competing probiotics can reach even with strong individual-strain literature. The caveats are real, though: several of DS-01's dermatological and cardiovascular claims rest on strain-family or species-level evidence rather than DS-01-specific outcome data, per-strain AFU dosing within the blend is not disclosed, no public batch-level COA exists, and in the EU the word 'probiotic' itself cannot legally carry a health claim under EFSA's long-standing, category-wide rejection, a regulatory reality that applies to DS-01 exactly as it does to every competitor. Buyers should also weight the sharp contrast between the underlying science and Seed's poor Trustpilot/BBB scores, which center almost entirely on subscription billing and customer-service friction rather than on whether the product itself works.

Bevisning, what actually backs this product

Longevity brands rarely test their exact finished product. We separate what's tested from what's inferred.

Strongest evidence tier

Tier 1Product RCT (peer-reviewed)

8 studies mapped

Tier 0No source

Why the European Food Säkerhet Authority was right to reject health claims for probiotics

Katan MB · 2012 · European Tidskrift of Clinical Nutrition (commentary) · N/A · N/A

ingredient-levelpeer-reviewed

Explains and defends EFSA's category-wide rejection of health claims for probiotics under EU Regulation 1924/2006, citing insufficient intervention-trial evidence across the category.

Included for regulatory context, not efficacy evidence for DS-01 specifically. Relevant because it explains why DS-01 (and every other probiotic) cannot carry authorized health claims in the EU regardless of underlying trial quality.

Conflicts: None identified.

Tier 1Product RCT (peer-reviewed)

A Randomized, Placebo-Controlled Trial Evaluating Multi-Species Synbiotic Supplementation for Bloating, Gas, and Abdominal Discomfort

Allegretti JR, Kassam Z, Kelly CR, Grinspan A, El-Nachef N, Van Den Elzen C, Jäger R, Feuerstadt P · 2026 · Nutrients · n=350 · 53.6 billion AFU multi-species probiotic + 400 mg Indian pomegranate extract (2 capsules/day) = full label dose of DS-01 · 6 weeks

on this exact productpeer-reviewed

DS-01 significantly improved GI quality of life, reduced bloating/gas (72.3% vs 55.9% reporting never/rarely bloating, p<0.001), reduced abdominal discomfort (p<0.01), and improved constipation/regularity symptoms versus placebo, with no significant difference in adverse events.

This is a Tier-1-caliber trial: peer-reviewed, on the exact finished DS-01 SKU at label dose, largest RCT of its kind in this category. Trial was run by Radicle Science Inc. (a decentralized-trial vendor) in collaboration with academic gastroenterologists; funded/sponsored by Seed Health, whose CMO is a co-author. Self-reported symptom population (not clinically diagnosed IBS), so generalizability to diagnosed GI disease is limited, and self-report outcome measures (even if validated instruments) carry some risk of placebo response inflation typical of GI symptom trials.

Conflicts: Sponsored by Seed Health, Inc.; Zain Kassam and Courtney Van Den Elzen are Seed Health employees and co-authors; Radicle Science (contract research organization) conducted the trial.

Tier 2Product RCT (not peer-reviewed)

Multi-Species Synbiotic Supplementation Enhances Gut Microbial Diversity, Increases Urolitin A and Butyrate Production, and Reduces Inflammation in Healthy Adults: A Randomized, Placebo-Controlled Trial

Not fully disclosed in available abstract; Seed Health-affiliated authorship consistent with company press materials · 2025 · Nutrients · n=32 · 53.6 billion AFU multi-species probiotic + 400 mg Indian pomegranate extract (DS-01, full label dose) · 91 days

on this exact productpeer-reviewed

DS-01 significantly increased alpha-diversity of Bifidobacterium/Lactobacillus at all timepoints (p<0.0001 by Day 91), increased urinary Urolitin A (12-fold at Day 7, 49-fold at Day 91, p<0.001), converted 100% of participants into Urolitin A producers vs. 44.4% on placebo (p<0.01), and increased fecal butyrate in low-baseline-butyrate producers while lowering systemic CRP.

On the exact finished product at label dose; peer-reviewed. Small sample (N=32) limits statistical power for some secondary outcomes (e.g., CRP reduction subgroup) and this appears to be the same broad DS-01 metabolite/microbiome research program referenced in Seed's PR materials on Urolitin A and butyrate. Mechanistic/biomarker endpoints (Urolitin A, butyrate, CRP) are surrogate markers, not direct clinical outcome measures like symptom relief.

Conflicts: Sponsored by Seed Health, Inc.

Tier 2Product RCT (not peer-reviewed)

Impact of a multi-species synbiotic (DS-01) on microbiome resilience and gastrointestinal barrier function after antibiotics: A randomized, dubbelblind, placebokontrollerad clinical trial

Seed Health-affiliated research team; presented at Digestive Disease Week (DDW) 2024 · 2024 · Conference abstract (DDW 2024); not yet identified as a separate full peer-reviewed journal article at time of review · DS-01, 2 capsules daily (registered protocol; full label dose) · Up to 91 days post-antibiotic

on this exact productnot peer-reviewed

DS-01 enhanced short-term (25% at Day 7) and long-term (49% by Day 91) gut barrier integrity following antibiotics, restored baseline microbial diversity, and enriched beneficial bacteria versus placebo.

Registered on ClinicalTrials.gov (Principal Investigator: Anthony J. Lembo, MD, Beth Israel Deaconess Medical Center) but as of this review we could only verify the conference abstract/press release, not a peer-reviewed journal publication with full methods and statistics. Downgraded relative to the published Nutrients trials because full peer review could not be confirmed.

Conflicts: Sponsored by Seed Health, Inc.

Tier 2Product RCT (not peer-reviewed)

A multi-species synbiotic (DS-01) alleviates irritable bowel syndrome symptoms while boosting synbiotic consortium: A randomized, dubbelblind, placebokontrollerad clinical trial

Seed Health-affiliated research team with Harvard-affiliated clinical sites; presented at Digestive Disease Week (DDW) 2024 · 2024 · Conference abstract (DDW 2024) · n=100 · DS-01, 2 capsules daily (full label dose) · Not fully disclosed in available materials

on this exact productnot peer-reviewed

DS-01 led to a significant and clinically meaningful improvement in abdominal pain among IBS participants, enrichment of synbiotic and endogenous beneficial bacteria, and a significant increase in serotonin in IBS-M participants.

This is the trial referenced by third-party reviewers (e.g., healthrx.com) as 'the one published DS-01 RCT' in IBS-C at N=40 in 2023 -- our research found the registered protocol targets N=100 and was conducted under FDA IND at Harvard's Beth Israel Deaconess Medical Center, with results presented at DDW 2024, but we could not confirm a subsequent full peer-reviewed journal publication with complete statistics as of this review. Treat DDW conference-abstract-stage results as provisional until peer-reviewed.

Conflicts: Sponsored by Seed Health, Inc.

Tier 4Ingredient RCT (different dose)

Bifidobacterium longum BB536 in defecation frequency and constipation in elderly adults receiving enteral feeding

Kondo et al. · 2023 · Cited via review: Efficacy of Bifidobacterium longum alone or in multi-strain formulations · n=206 · 5 x 10^10 CFU/day (or 2.5 x 10^10 CFU in Trial 2 arm) of B. longum BB536 · 16 weeks

ingredient-levelpeer-reviewed

B. longum BB536 significantly normalized defecation frequency in both low- and high-frequency defecation subjects.

This is independent third-party evidence for the species/strain 'Bifidobacterium longum BB536' used generically in the literature; DS-01 contains B. longum SD-BB536-JP, which Seed's own Reference Library associates with this strain family, but the per-strain AFU dose delivered within DS-01's 37-billion-AFU 16-strain blend is not disclosed, so exact dose-matching to this 5x10^10 CFU monotherapy dose cannot be confirmed.

Conflicts: Not disclosed in available secondary source; original study conducted independently of Seed Health.

Tier 5Mechanistic / animal / marketing

Probiotics, Immune Function, and the Brain in Alcohol Use Disorder (ancillary DS-01 sub-study)

Monnig M (Principal Investigator), Brown University; NIH-funded · 2022 · ClinicalTrials.gov registration (results not yet published as of this review) · Seed DS-01 Daily Synbiotic · 30 days

on this exact productnot peer-reviewed

Single-group, open-label study measuring inflammatory/immune biomarkers (LBP, sCD14, sCD163, IL-6, MCP-1, TNF-alpha) before/after 30 days of DS-01; independently NIH-funded (P01AA019072) and not industry-designed, but open-label with no placebo arm and results not yet published.

Independently initiated academic study (Brown University) rather than a Seed-sponsored trial, which is a positive credibility signal, but the single-arm open-label design without a placebo control means it cannot establish causal efficacy on its own.

Conflicts: NIH grant-funded; no disclosed Seed Health sponsorship identified in the registration.

Tier 5Mechanistic / animal / marketing

Cholesterol-lowering efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolaemic adults

Fuentes MC, Lajo T, Carrión JM, Cuñé J · 2013 · British Tidskrift of Nutrition · n=60 · 1.2 x 10^9 CFU/day of a 3-strain L. plantarum mixture · 12 weeks

ingredient-levelpeer-reviewed

Significant 13.6% reduction in total cholesterol versus placebo; larger reductions (15-17%) in participants with higher baseline cholesterol.

This is species-level (L. plantarum), not the exact proprietary SD-LPLDL-UK strain in DS-01's Cardiovascular Health blend, and uses a different specific strain combination (CECT 7527/7528/7529) at a different dose than DS-01's 5.25-billion-AFU 2-strain blend. Included as ingredient-class supporting evidence, not exact-strain confirmation; DS-01's marketing materials reference 'LPLDL' informally as cholesterol-supportive but the exact strain code is not independently indexed under a matching PubMed record.

Conflicts: Not disclosed in abstract; unrelated to Seed Health.

Bevisning

Research behind this product

No landmark studies linked yet. See the ingredient pages for the full evidence breakdown.

Claim check, vendor claims vs. our reading of the evidence

Not medical advice. We list the strongest claims made by the brand and check each against traceable evidence.

Supported

“'53.6 Billion AFU' across 24 clinically-studied probiotic strains plus a polyphenol-based prebiotic”

The AFU count, strain count, and prebiotic dose are consistently documented on Seed's own Reference Library label breakdown (https://seed.com/reference/syn-wk) and independently corroborated in the peer-reviewed Nutrients trial methods section, which describes the identical formulation (53.6 billion AFU multi-species probiotic and 400 mg pomegranate extract). AFU (Active Fluorescent Units, measured by flow cytometry) is a real but non-standard alternative to the more common CFU metric; it is not directly comparable to CFU counts on competitor labels, which can make cross-brand potency comparisons difficult for consumers.

Supported

“DS-01 is 'clinically-studied' / has clinical trials on the exact formula”

Verified independently: DS-01 at full label dose (53.6 billion AFU + 400 mg pomegranate extract) has been tested in at least two published, peer-reviewed RCTs in Nutrients (N=350, 6 weeks, PMC12845427; and N=32, 91 days, PubMed 40944126), plus two additional DBRCTs presented at Digestive Disease Week 2024 that have not yet been confirmed as separately peer-reviewed. This places DS-01 well ahead of the vast majority of probiotic finished produkter, which typically carry zero trials on the actual sold SKU.

Unverifiable

“ViaCap® 2-in-1 delivery technology delivers ~100% of the probiotic dose intact to the colon, surviving stomach acid, bile, and digestive enzymes”

This claim rests on Seed's own in-house SHIME (Simulator of the Human Intestinal Microbial Ecosystem) laboratory model, an accepted in vitro digestion-simulation method in the field, but we could not locate an independently published, peer-reviewed paper validating this specific ~100% survival figure for DS-01's exact capsule system. In vitro simulator results also do not guarantee identical in vivo colonization or survival in every individual gut environment. We treat this as a plausible, mechanistically reasonable claim that remains company-generated and independently unverified.

Partial support

“Systemic/whole-body benefits including digestive health, gut barrier integrity, immune support, skin health, and heart health”

Digestive-health and gut-microbiome-composition benefits are supported by the DS-01-specific RCTs (bloating, regularity, GI quality of life; Bifidobacterium/Lactobacillus alpha-diversity increases). Gut barrier integrity is supported by DS-01's antibiotic-recovery trial data (49% improvement claim), though that trial's full peer-reviewed publication was not confirmed. Skin health and cardiovascular claims rely on strain-family literature for individual ingredients in the Dermatological and Cardiovascular blends (e.g., published work on B. lactis CECT8145-adjacent strains and L. plantarum cholesterol studies) rather than DS-01-specific clinical endpoints for those outcomes, no DS-01 trial reported skin or lipid-panel outcomes as of this review. This is a case where some claims sit at Tier 1-2 (digestive) and others sit at Tier 4-5 (skin, heart) within the same product.

Partial support

“Strains are 'clinically and scientifically studied' at academic institutions in Italy, Spain, Belgium, US, and Japan”

Seed's Reference Library cites a real table of strain-family benefit studies (e.g., Del Piano 2010, Costabile 2017, Navarro-López JAMA Dermatol 2018), and several of DS-01's proprietary strain codes clearly derive from established academic/industry strain-culture collections (Italian, Spanish [CECT], Belgian, Japanese [BB536] origins are traceable). However, many of the cited studies are on the parent strain family or species-level, in vitro, or in different populations (e.g., pediatric atopic dermatitis, Parkinson's disease cell models) rather than head-to-head clinical trials of Seed's exact proprietary strain isolate at the exact AFU dose delivered within the DS-01 blend, which Seed's own footnotes acknowledge (marking several claims '*Claim substantiated through in vitro research').

Regelverk status

Rules change often. We record when we last verified each row. See the full regulatory timeline →

What we could not verify

We list this openly. If a claim isn't backed by a source we can trace, we'd rather flag it than repeat it.

No public, batch-level Certificate of Analysis (COA) is available for consumers to review; Seed states it tests every batch but does not publish underlying lab reports.
The specific third-party testing laboratory/labs used for AFU potency, heavy metals, and pesticide screening are not named on the public product or reference pages.
Exact per-strain AFU dosing within each of the four sub-blends (Digestive Health, Dermatological, Cardiovascular, Micronutrient Synthesis) is not disclosed, only blend totals are listed, so it cannot be confirmed whether any single strain is dosed at the same level used in its underlying published research.
The two DS-01 DBRCTs presented at Digestive Disease Week 2024 (antibiotic recovery and IBS) were not confirmed as fully peer-reviewed journal publications as of this review; they remain at conference-abstract stage in the evidence we could locate.
The precise manufacturing facility location and its specific accreditations (e.g., whether it is truly EU-pharmaceutical-GMP and ISO-certified, as claimed by at least one third-party reviewer) could not be confirmed via a primär Seed Health source.
Seed does not hold NSF Certified for Sport or USP Verified independent certification, which several independent reviewers flag as a transparency gap relative to some certified competitors.

Important to know

ProbioticsRefrigerated ≠ better if the strain is shelf-stable. Look for CFU at expiry, not at manufacture.

Redaktionellt notes

24 strains, 53.6B AFU, prebiotic-in-capsule design.

In plain language

Why this scored this way

This Seed Health DS-01® Daily Synbiotic scores 6.4, making it below the site average. It contains 900mg of Probiotics with grade B evidence (promising human data, not yet comprehensive).

What drives the score up

Tested by independent lab (transparency 8.5).

What drags it down

Dose-evidence score of 5.6 is below average for the site.
No public analysintyg available for independent verification.

Why you'd choose it

You want Probiotics from a Seed Health product.
You want a tested by independent lab product.

Why you might skip it

You want a product with a publicly available CoA.
You want a higher-scoring product (this scores 6.4).

Go deeper

Where this sits

Actives inside

Probiotics

Kategori

Se alla in Microbiome →

Varumärke

Seed Health profile →

Jämför this product → Visit brand site →

Varumärke owners

Spot an error?

If you are the manufacturer or brand owner of DS-01® Daily Synbiotic and believe any data on this page is incorrect (wrong dose, wrong ingredient, wrong price, missing certification, outdated status), you can request a correction.

We review every request, verify it against primär sources, and publish any change with a dated note in the version history above. Corrections from brand owners are treated the same as corrections from anyone else: verified before they move.

Request a correction →

Same maker

Other produkter from Seed Health

Varumärke profile →

Seed DM-02 Daily Multivitamin

6.5

Multi/greens

100%

Överensstämmer med studier

$1.33

per dag

Lab-testat

Pris kontrollerat aug 2026 · seedhealth.com

Seed AM-02 Energy + Focus

5.4

Cognition

0.3%

Överensstämmer med studier

$358.87

per dag

Lab-testatEU restricted

Pris kontrollerat aug 2026 · seedhealth.com